Invitation to presentation of Xbrane Biopharma’s Year-end report 2022 on February 17, 2023.

Corporate Information




Other Corporate Information

Xbrane Biopharma AB (publ) (“Xbrane” or “the Company”) (Nasdaq Stockholm: XBRANE), invites to a teleconference for investors, analysts and media on Friday, February 17, 2023, at 10.00 a.m. CET. Xbrane will publish the company’s Year-end report 2022, on Friday, February 17, 2023, at 8.00 a.m. CET.

Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the Year-end report 2022, followed by a Q&A session. The presentation will be in English. To attend, please follow the link or dial-in at one of the numbers below:
Web link:
Webcast URL

Conference call dial in details, Participants:
Online Registration: